RECRUITING

Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression

Description

This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.

Conditions

Opioid UseLumbar Spinal StenosisPain, PostoperativePain, Back
Talk to us

Related Conditions:

Opioid UseLumbar Spinal StenosisPain, PostoperativePain, Back

Study Overview

On this page

Study Details

Study overview

This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.

Topical Epidural Steroid Usage in Patients Undergoing Posterior Lumbar Decompression: A Randomized Control Trial

Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression

Condition
Opioid Use
Intervention / Treatment

-

Contacts and Locations

New York

Hospital for Special Surgery, New York, New York, United States, 10021

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients scheduled to undergo 1 to 2 level laminectomy
  • * Between the ages of 18-85
  • * Minimally invasive surgery
  • * Prior daily opioid usage within 6 months.
  • * Use of concomitant procedures such as spinal fusion, revision procedure at the same level.
  • * History of a chronic pain syndrome, uncontrolled diabetes defined as A1C \> 6.5, immunocompromised condition such as active cancer treatment, history of transplant, benign prostatic hyperplasia or history of urinary retention, and other conditions which require chronic steroid therapy or immunosuppressants.
  • * Non-English speakers
  • * Patients allergic to Depo-Medrol and/or glucocorticoids, or other steroids

Ages Eligible for Study

18 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Hospital for Special Surgery, New York,

Study Record Dates

2024-12-31